Halog

NDA 17818, held by Westwood Squibb. Halcinonide.

As of Nov 13, 2026, NDA 17818 (Halog), held by Westwood Squibb, was first approved by FDA on Jun 15, 1977, with 2 approved supplements and 0 published complete response letters.

First approved: Jun 15, 1977
Review: Standard
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Jun 15, 1977	Original applicationNew dosage form · Standard review	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Halog0.025% · cream;topical	Halcinonide	DiscontinuedReference drug

All 3 submissions, including labeling and manufacturing supplements


Nov 26, 1982	Supplement 9Labeling	Approved	None posted
Mar 24, 1980	Supplement 8Labeling	Approved	None posted
Jun 15, 1977	Original applicationNew dosage form · Standard review	Approved	None posted

Identifiers

Application: NDA 17818
Drugs@FDA: Overview at FDA
Company: Westwood-Squibb Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters